GLP-1 Telehealth: What Prescribers Need to Know in Illinois

If you’re a psychiatrist watching GLP-1 drugs dominate headlines — patients asking about Ozempic, colleagues mentioning six-figure side hustles in weight loss — you’ve probably wondered: Is this actually a legitimate opportunity for my practice, or just hype?

Here’s the reality: By 2025, an estimated 20 million Americans (6% of the population) were actively taking GLP-1 medications, representing a 600% increase in weight-loss usage over six years. This isn’t a fad — it’s a fundamental shift in how obesity is treated. And psychiatrists are uniquely positioned to capture this market.

Unlike primary care docs drowning in patient panels or endocrinologists focused on diabetes, psychiatrists already understand behavior change, mental health comorbidities, and long-term medication management. You’re also likely already prescribing to patients dealing with antipsychotic-induced weight gain or binge eating disorder. The infrastructure is there. The patient need is screaming. The question is whether you want to build this into your practice — and whether you can do it without adding ‘telehealth weight-loss clinic burnout’ to your resume.

This guide walks through exactly how general psychiatrists can build a scalable, profitable GLP-1 practice while protecting their sanity, navigating state regulations, and avoiding the common pitfalls that sink overextended providers.

Why Psychiatrists Are Actually Perfect for GLP-1 Care

You Already Treat the Root Causes of Obesity

Nearly half of psychiatrists surveyed in late 2023 were already prescribing or recommending weight-loss medications like Ozempic — often to counteract medication-induced weight gain from antipsychotics, mood stabilizers, or certain antidepressants. If you’ve ever watched a patient gain 40 pounds on olanzapine and felt helpless, GLP-1s offer a legitimate intervention.

But it goes deeper than medication side effects. Obesity and mental health are profoundly intertwined:

• Binge eating disorder, emotional overeating, and food addiction frequently co-occur with depression and anxiety
• Weight stigma contributes to poor self-image and social withdrawal
• Rapid weight loss can trigger mood instability in some patients (something you’re trained to monitor)
• The psychological barriers to sustained weight loss — motivation, self-sabotage, all-or-nothing thinking — are core psychiatric territory

Primary care physicians typically have 15 minutes to address weight in between managing diabetes, hypertension, and prior authorizations. You have the time, training, and therapeutic relationship to actually support lasting behavior change. That’s your competitive advantage.

The Patient Demand Is Staggering (and Growing)

With roughly 75% of Americans overweight or obese, and only a tiny fraction of obesity medicine specialists to treat them, tens of thousands of new patients start GLP-1 treatments every week. The bottleneck isn’t patient interest — it’s provider capacity.

Many of these patients are already your patients. They’re on your psychiatric medications. They’re dealing with emotional eating. They’re asking their therapists about Wegovy. If you don’t offer it, they’re finding it from online telehealth companies with zero psychiatric expertise — companies that may miss contraindications, ignore mood changes, or fail to address the behavioral component of weight loss.

By integrating GLP-1 care into your practice, you’re not ‘pivoting away’ from psychiatry — you’re treating the whole patient in a way most providers can’t.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Business Case: Cash-Pay vs. Insurance

Before diving into clinical protocols, let’s address the elephant in the room: How do you actually get paid for this?

Why Most GLP-1 Practices Are Cash-Pay

Insurance coverage for GLP-1 obesity treatment remains spotty. While most plans cover these drugs for diabetes, only 13 state Medicaid programs covered GLP-1s for weight loss as of mid-2024 (California, Pennsylvania, and Illinois were among them — Texas, Florida, and New York were not). Many private insurers still exclude obesity medications as ‘not medically necessary’ unless the patient has multiple comorbidities.

The result? Most patients pay out-of-pocket — for both the medication and the provider visits. This creates a natural cash-pay market.

Typical cash-pay structures:

• Monthly subscription model: Patients pay $99-299/month for provider visits, care coordination, and often discounted compounded semaglutide (avoiding the $1,300+ brand-name Wegovy cost)
• Per-visit model: Initial consult $150-250, follow-ups $75-150 every 4-6 weeks
• Hybrid: Cash initial visit, then insurance billing for follow-up E/M codes or obesity counseling (G0447 for Medicare patients)

The advantage of cash-pay: No prior authorizations, no fighting with insurance, no claims denials. You set your fee, patients pay directly, and you focus on care. It also attracts motivated patients — people spending their own money tend to be more engaged in treatment.

The insurance route: If you want to serve patients who can’t afford cash-pay, you can bill standard E/M codes for obesity management visits. The challenge is extensive documentation requirements and variable reimbursement (often $50-150 per visit after contractual adjustments). You’ll also spend time coordinating prior authorizations for medications, which insurance often denies initially.

What most successful practices do: Start cash-pay to build volume and test workflows, then selectively accept insurance for follow-up care once you’ve streamlined operations. Some providers offer a ‘membership tier’ — pay cash for premium access (same-day messaging, longer appointments) or use insurance for standard care.

The Real Economics of Patient Acquisition

Let’s be blunt about marketing costs because many ‘start a telehealth practice’ guides gloss over this:

DIY marketing is expensive and slow. Building an SEO presence takes 6-12 months and thousands of dollars in content creation and technical optimization. Google Ads for mental health and weight-loss keywords cost $15-40+ per click, and most clicks don’t convert to booked patients — you’re looking at $200-400+ per actual appointment when you factor in wasted ad spend, no-shows from cold leads, and agency fees.

Psychology Today and Zocdoc charge monthly fees ($30-100+) and you’re competing with hundreds of other providers on the same page. Even with listings, you’re paying for visibility with no guarantee of patient flow.

Platform-based patient acquisition changes the math: Services like Klarity Health use a pay-per-appointment model where you pay a standard listing fee only when a pre-qualified patient books with you. No upfront ad spend, no monthly subscriptions, no gambling on SEO. You control your schedule and only pay when you see patients — guaranteed ROI versus the uncertainty of DIY marketing.

For most providers, especially those starting out or scaling quickly, removing patient acquisition risk entirely is worth the per-appointment fee. You can always layer in your own marketing later once you’ve built clinical capacity and cash flow.

Clinical Workflows That Scale Without Killing You

The biggest mistake psychiatrists make when adding GLP-1 care? Treating it like standard psychiatric practice — hour-long deep-dive assessments, endless messaging, no delegation. That’s a recipe for burnout.

Here’s how to structure a GLP-1 practice that can handle 50-100+ patients without working weekends:

Phase 1: Streamlined Intake (30-45 minutes)

Before the visit:

• Digital intake form captures weight history, past diet attempts, medical conditions, current medications, mental health screening, and basic labs (A1c, TSH, lipids if available)
• Standardized exclusion criteria: history of medullary thyroid cancer, pancreatitis, pregnancy/breastfeeding, severe gastroparesis
• BMI calculation automated (≥30 for FDA-approved use, ≥27 with comorbidities)

During the visit:

• Confirm medical appropriateness (rule out contraindications)
• Set realistic expectations: ‘This medication helps reduce appetite and cravings, but it works best combined with nutrition changes and movement. Expect 10-15% body weight loss over 6-12 months, not overnight transformation.’
• Mental health screening: history of eating disorders, mood instability with weight changes, suicidal ideation (early studies raised concerns about GLP-1s and suicidal thoughts, though the FDA found no causal link by 2026 — still worth monitoring given your expertise)
• Discuss side effects (nausea, constipation, injection technique) and medication logistics (starting dose, titration schedule)
• Prescribe starter dose (typically semaglutide 0.25mg weekly for first month)

Key documentation: Informed consent for off-label use if prescribing Ozempic for obesity, baseline weight/BMI, treatment plan with dosing schedule, patient education provided.

Phase 2: Efficient Follow-Ups (15-20 minutes)

Month 1-3 (dose titration phase): Monthly video visits to:

• Review weight change and side effects
• Adjust dose per protocol (standard is 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg for semaglutide, increasing every 4 weeks as tolerated)
• Brief counseling on nutrition, hydration, exercise
• Screen for mood changes or concerning behaviors

Month 4-6 (stabilization): Every 6-8 weeks once on maintenance dose

• Weight check (many practices issue connected scales for remote monitoring)
• Medication refills
• Troubleshoot plateaus or side effects

Month 6+ (maintenance): Every 2-3 months for stable patients, with asynchronous check-ins (weekly weight logs via patient portal, quick message support)

Delegation Is Your Secret Weapon

What you should NOT be doing:

• Answering ‘Is nausea normal?’ messages at 9 PM (create templated autoresponders with common side effect management)
• Spending 20 minutes teaching injection technique every visit (make a 3-minute video, send it to all patients)
• Tracking down lab results (have a medical assistant or RN handle)
• Discussing meal plans in detail (partner with or refer to a dietitian, or run group nutrition sessions)

What scales:

• Medical assistants handle intake forms, schedule follow-ups, triage messages
• RNs or health coaches conduct interim check-ins (Week 2 post-start: ‘How’s the nausea? Are you tolerating the dose?’)
• Group teletherapy sessions (monthly 30-minute Zoom groups for Q&A, motivation, troubleshooting) can support 20-30 patients at once
• Automated reminders for lab work, refills, and weight logging reduce your administrative burden

The result: You focus on medical decision-making — dose adjustments, managing complex cases, handling mental health interactions — while support staff handles the routine. A psychiatrist can realistically manage 100-150 active GLP-1 patients this way without burnout, generating $10,000-30,000+ monthly in additional revenue depending on your model.

State-Specific Regulations: What You Need to Know

GLP-1 medications are not controlled substances, which means you can prescribe them via telehealth without the Ryan Haight Act’s in-person exam requirement. However, you must be licensed in your patient’s state and follow that state’s scope-of-practice rules.

For Psychiatrists (MD/DO):

You have full prescriptive authority in all 50 states. The main consideration is licensure:

• IMLC states (Texas, Florida, Pennsylvania, Illinois): Use the Interstate Medical Licensure Compact for expedited multi-state licensing if you want to treat patients in multiple states
• Non-IMLC states (California, New York): Full individual state licensure required

Florida offers a special shortcut: Out-of-state physicians can register as telehealth providers without full Florida licensure (with some limitations on controlled substances, but GLP-1s are unaffected). This makes Florida particularly accessible for expanding your reach.

For Psychiatric NPs (PMHNPs):

Your scope varies significantly by state:

• Independent practice states: California (starting 2026 for experienced NPs), New York (after 3,600 hours), Illinois (after 4,000 hours + training) — you can prescribe GLP-1s without physician oversight once qualified
• Collaborative states: Texas, Pennsylvania, Florida (for psych NPs) — you must have a written collaborative agreement with a physician to prescribe

If you’re a PMHNP in a collaborative state, you need to either:

• Partner with an MD/DO willing to oversee your GLP-1 practice (which involves chart review and availability for consult)
• Join a platform or practice that provides supervising physicians

Bottom line: Every state permits GLP-1 prescribing via telehealth. The question is whether you need a collaborating physician and how easy it is to get licensed.

Telehealth-Specific Rules

Most states now allow telehealth-only patient relationships for non-controlled prescriptions. Key compliance points:

• California: Requires documented patient consent for telehealth
• Texas: Allows audio-visual relationship establishment; requires standard-of-care evaluation
• Florida: No prior in-person visit required if telehealth exam is adequate
• New York, Pennsylvania, Illinois: Same standard of care as in-person; video evaluation typically sufficient

What ‘standard of care’ means: Take a thorough history, assess appropriateness, document your evaluation, obtain informed consent, and provide patient education — exactly what you’d do in person. Most malpractice carriers accept this as long as it’s documented.

Avoiding Burnout: The Non-Negotiables

Adding a high-volume service line is exciting — and dangerous. Here’s how to protect yourself:

1. Set Hard Capacity Limits

Start with 5-10 new GLP-1 patients per week while you refine workflows. Once efficient, cap your weekly intake at a sustainable number (10-15 for most solo practitioners). It’s better to have a waitlist than to overextend.

2. Batch Similar Work

Schedule all initial GLP-1 consults on specific days (e.g., Tuesday/Thursday mornings), all follow-ups on different slots. This reduces mental task-switching and makes it easier to delegate support tasks.

3. Automate Ruthlessly

Use EHR templates, automated messaging, online scheduling, and portal-based intake. Every manual task you eliminate compounds across hundreds of patients.

4. Maintain Boundaries

Set clear communication hours (no after-hours messaging for non-emergencies). Use auto-responders: ‘I’ll respond to non-urgent messages within 24 business hours.’ Patients who pay cash typically respect boundaries when they’re clearly set.

5. Delegate or Die

If you’re doing everything yourself — intake, billing, messaging, prior auths — you’ll burn out by month three. Hire a part-time virtual assistant ($15-25/hour) or medical assistant (even 10 hours/week makes a huge difference). Once you’re seeing 30+ GLP-1 patients monthly, the ROI on support staff is immediate.

6. Monitor Your Own Metrics

Track not just revenue but your own well-being: Are you working more hours? Feeling depleted after patient sessions? Resenting your practice? These are early burnout signs. If you see them, pause new patient intake and optimize workflows before scaling further.

The Bottom Line: This Is a Real Opportunity (If You Do It Right)

The GLP-1 boom isn’t hype. With 20 million Americans already on these medications and millions more trying to access them, the patient demand won’t disappear. Medicare is piloting coverage. More states are adding Medicaid coverage. Compounded semaglutide has made treatment accessible at lower price points.

For psychiatrists, this represents a legitimate practice expansion opportunity:

• Leverage existing skills (medication management, behavior change, mental health screening)
• Serve underserved patients (people struggling with obesity who can’t access specialists)
• Generate additional revenue ($5,000-30,000+/month depending on volume and model)
• Provide truly integrated care (addressing physical and mental health together)

But only if you build it sustainably. The psychiatrists who succeed in this space aren’t the ones who add GLP-1s as an afterthought and drown in unstructured patient volume. They’re the ones who:

• Start small and test workflows before scaling
• Use technology and delegation to multiply their capacity
• Set clear boundaries and protect their time
• Focus on patient quality, not just quantity
• Remain humble about what they don’t know (partner with dietitians, endocrinologists when needed)

If you’re curious about adding GLP-1 care to your practice, start by talking to 5-10 of your current patients who might benefit. See if you enjoy the work. Refine your intake process. Then decide whether to scale independently or join a platform that handles patient acquisition and infrastructure while you focus on clinical care.

The opportunity is real. The question is whether you want to capture it — and whether you’re willing to do it in a way that enhances rather than exhausts your practice.

Frequently Asked Questions

Do I need special obesity medicine certification to prescribe GLP-1s?

No. As a licensed psychiatrist, you have full prescriptive authority for these medications. Obesity medicine certification (through ABOM) can be valuable for knowledge and credibility, but it’s not required. Many psychiatrists start prescribing after completing CME courses on GLP-1s and obesity management (20-30 hours of education is a reasonable foundation).

Can I prescribe GLP-1s to out-of-state patients?

Only if you’re licensed in their state. You can use the Interstate Medical Licensure Compact (IMLC) to expedite licensing in member states (Texas, Florida, Pennsylvania, Illinois), or pursue individual state licenses (required for California and New York). Some platforms handle multi-state licensing logistics for their providers.

What if a patient has concerning mood changes on GLP-1s?

This is where your psychiatric training is invaluable. While the FDA found no causal link between GLP-1s and suicidal ideation, rapid weight loss, body image shifts, and medication effects can impact mood. Screen at every follow-up, adjust psychiatric medications if needed, and consider pausing or discontinuing the GLP-1 if mood instability worsens. Document your clinical reasoning thoroughly.

How do I handle patients who want GLP-1s but don’t meet medical criteria?

Set clear expectations upfront: FDA approval is for BMI ≥30 or ≥27 with comorbidities. For patients below this threshold seeking ‘cosmetic’ weight loss, explain the risks, limited evidence, and your clinical judgment. Many psychiatrists decline these cases to focus on patients with legitimate medical need. If you do prescribe off-label for lower BMI, document extensive informed consent.

What about compounded semaglutide — is it legal?

Yes, but with caveats. The FDA has issued warnings about compounded GLP-1s from unregulated sources. Work only with 503B outsourcing facilities (FDA-registered compounding pharmacies that follow quality standards). Verify their credentials and inform patients they’re receiving a compounded product, not FDA-approved branded medication. Many telehealth platforms vet compounding pharmacy partners for you.

How do I compete with $99/month online GLP-1 clinics?

Don’t compete on price — compete on quality. Your value proposition as a psychiatrist:

• Integrated mental health and weight management (most online clinics are staffing with random NPs who know nothing about psychiatric comorbidities)
• Continuity of care for existing patients
• Expertise in medication interactions and complex cases
• Behavioral support beyond ‘here’s your prescription’

Market to patients who’ve had bad experiences with impersonal telehealth mills or who want a provider who actually knows them.

Can I bill insurance and also charge a cash program fee?

Generally no — this creates ‘double-dipping’ issues. If you’re billing insurance for visits, you can’t charge a concurrent membership fee for the same services. You can offer optional add-ons that insurance doesn’t cover (group coaching, after-hours messaging, nutrition consultations) as separate cash-pay services. Consult a healthcare billing attorney if you’re unsure.

What’s the typical patient retention rate?

Highly variable. Many patients stay on GLP-1s for 12-24+ months (some indefinitely). Discontinuation happens due to side effects (~10-20%), reaching goal weight, cost concerns, or insurance loss. Build retention through regular touchpoints, behavioral support, and helping patients transition to maintenance dosing rather than abrupt discontinuation. Retained patients become your most profitable (minimal intake time, quick follow-ups).

References

1. Axios. ‘Just how many Americans are taking GLP-1s now.’ May 27, 2025. Available at: https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews. ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ October 20, 2025. Available at: https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry

3. Time. ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ August 22, 2025. Available at: https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios. ‘America’s doctors need more obesity medicine training.’ May 28, 2024. Available at: https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios. ‘States slow to cover GLP-1s for weight loss.’ November 5, 2024. Available at: https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is